NCI

Cancer nanomedicines on target

Therapeutic nanoparticles may offer a powerful new way to image and treat cancer at the same time.

Deciphering DNA code

VU study identifies DNA changes in drug-resistant cancer cells

Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines.

Tumor factor spurs blood vessel growth

A newly identified factor regulates blood vessel growth in colorectal tumors and could be a promising target for cancer therapies.

Overcoming resistance in ovarian cancer

The nuclear receptor TR3 contributes to ovarian cancer cell death in response to platinum-based chemotherapy – and may be a good target for overcoming cell resistance to certain treatments.

Noninvasive test detects stomach bug

A noninvasive test can be used to identify the presence of Helicobacter pylori and evaluate its virulence, which will be useful in areas with high rates of H. pylori-associated gastric cancer.

Motor protein revs up cell division

A motor protein that helps drive cell division may be a promising new target for cancer therapeutics.

1 19 20 21 22 23 28